169 related articles for article (PubMed ID: 34846678)
1. In Vivo Evaluation of Near-Infrared Fluorescent Probe for TIM3 Targeting in Mouse Glioma.
Zhang M; Zhou Q; Huang C; Chan CT; Wu W; Li G; Lim M; Gambhir SS; Daldrup-Link HE
Mol Imaging Biol; 2022 Apr; 24(2):280-287. PubMed ID: 34846678
[TBL] [Abstract][Full Text] [Related]
2. Construction and Preclinical Evaluation of
Tao J; Zeng Z; He C; Meng L; Zhou W; Ren Y; Ma X; Wang Z; Liu J; Li D; Zhang Q; Zhao C; Yang Z; Zhu H
Mol Pharm; 2024 Feb; 21(2):944-956. PubMed ID: 38270082
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
4. In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis.
Yang Y; Zhang Y; Hong H; Liu G; Leigh BR; Cai W
Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2066-76. PubMed ID: 21814852
[TBL] [Abstract][Full Text] [Related]
5. Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma.
Huang R; Vider J; Kovar JL; Olive DM; Mellinghoff IK; Mayer-Kuckuk P; Kircher MF; Blasberg RG
Clin Cancer Res; 2012 Oct; 18(20):5731-40. PubMed ID: 22914772
[TBL] [Abstract][Full Text] [Related]
6. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with anti-T-cell immunoglobulin and mucin-domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma.
Kim KJ; Lee HW; Seong J
J Gastroenterol Hepatol; 2021 May; 36(5):1357-1365. PubMed ID: 33217056
[TBL] [Abstract][Full Text] [Related]
8. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
9. Combined Blockade of T Cell Immunoglobulin and Mucin Domain 3 and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Results in Durable Therapeutic Efficacy in Mice with Intracranial Gliomas.
Li J; Liu X; Duan Y; Liu Y; Wang H; Lian S; Zhuang G; Fan Y
Med Sci Monit; 2017 Jul; 23():3593-3602. PubMed ID: 28736431
[TBL] [Abstract][Full Text] [Related]
10. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer.
Liu JF; Wu L; Yang LL; Deng WW; Mao L; Wu H; Zhang WF; Sun ZJ
J Exp Clin Cancer Res; 2018 Mar; 37(1):44. PubMed ID: 29506555
[TBL] [Abstract][Full Text] [Related]
11. Targeting VPAC1 Receptors for Imaging Glioblastoma.
Tripathi SK; Kean R; Bongiorno E; Hooper DC; Jin YY; Wickstrom E; McCue PA; Thakur ML
Mol Imaging Biol; 2020 Apr; 22(2):293-302. PubMed ID: 31292914
[TBL] [Abstract][Full Text] [Related]
12. Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.
Houvast RD; Baart VM; Bhairosingh SS; Cordfunke RA; Chua JX; Vankemmelbeke M; Parsons T; Kuppen PJK; Durrant LG; Vahrmeijer AL; Sier CFM
Mol Imaging Biol; 2020 Dec; 22(6):1511-1522. PubMed ID: 32780212
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Near-Infrared Imaging Agents Targeting the PTPmu Tumor Biomarker.
Johansen ML; Vincent J; Rose M; Sloan AE; Brady-Kalnay SM
Mol Imaging Biol; 2023 Aug; 25(4):744-757. PubMed ID: 36695968
[TBL] [Abstract][Full Text] [Related]
14. IL8 derived from macrophages inhibits CD8
Zhao C; Wang D; Li Z; Zhang Z; Xu Y; Liu J; Lei Q; Han D; Huo Y; Liu S; Li L; Zhang Y
Int Immunopharmacol; 2023 Aug; 121():110457. PubMed ID: 37331296
[TBL] [Abstract][Full Text] [Related]
15. [Effect of
Shi Y; Abidan A; Li D; Zibigu R; Wang M; Zheng X; Kang X; Wang H; Li J; Zhang C
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Sep; 35(4):366-373. PubMed ID: 37926471
[TBL] [Abstract][Full Text] [Related]
16. The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo.
Zhong T; Zhao C; Wang S; Tao D; Ma S; Shou C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):783-792. PubMed ID: 33084973
[TBL] [Abstract][Full Text] [Related]
17. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
18. The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.
Kandel S; Adhikary P; Li G; Cheng K
Cancer Lett; 2021 Jul; 510():67-78. PubMed ID: 33895262
[TBL] [Abstract][Full Text] [Related]
19. TIM3
Chen K; Gu Y; Cao Y; Fang H; Lv K; Liu X; He X; Wang J; Lin C; Liu H; Zhang H; He H; Xu J; Li H; Li R
Br J Cancer; 2022 Jan; 126(1):100-108. PubMed ID: 34725458
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
